Here is a case report of a complete remission following decitabine/dendritic cell vaccine for a relapsed neuroblastoma:
http://pediatrics.aappublications.org/content/early/2012/12/19/peds.2012-0376.abstract
There is a clinical trial for this treatment recruiting synovial sarcoma pediatric patients (1 to 21 years old):